TMBR Made Big Gain

TMBR (TMBR:NYSEMKT) soared at $3.55, a gain of 75.7%. The stock got featured on our News Catalysts scanner on Fri 05 Mar 21 at 09:56 AM in the 'MISCELLANEOUS' category. From Wed 24 Feb 21, the stock recorded 30.00% Up Days and 45.45% Green Days

The stock spiked on Mon 01 Mar 21 at $2.41 with a volume of 7M+.

About TMBR (TMBR:NYSEMKT)

Timber Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. The company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing and control) and safety profiles. It is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), tuberous sclerosis complex (TSC), and localized scleroderma. Its development pipeline includes TMB-001 (Topical Isotretinoin), TMB-002 (Topical Rapamycin), and TMB-003 (Topical / Subcutaneous ET-A Receptor Antagonist).